Ameritas Investment Partners’s NovoCure NVCR Stock Holding History

Ameritas Investment Partners’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92.5K	Hold	8,489	–	–	﹤0.01%	1736
2025 Q4	$110K	Hold	8,489	–	–	﹤0.01%	1637
2025 Q3	$110K	Sell	8,489 -1,885	-18%	-$25.2K	﹤0.01%	1632
2025 Q2	$185K	Sell	10,374 -767	-7%	-$13.4K	0.01%	1338
2025 Q1	$199K	Hold	11,141	–	–	0.01%	1268
2024 Q4	$332K	Buy	11,141 +708	+7%	+$15K	0.01%	1026
2024 Q3	$163K	Hold	10,433	–	–	0.01%	1456
2024 Q2	$179K	Buy	+10,433	New	+$183K	0.01%	1349
2020 Q2	–	Sell	-7,610	Closed	-$512K	–	3114
2020 Q1	$512K	Buy	7,610 +187	+3%	+$14.8K	0.03%	615
2019 Q4	$626K	Buy	7,423 +199	+3%	+$16.1K	0.03%	689
2019 Q3	$540K	Sell	7,224 -10	-0.1%	-$800	0.02%	721
2019 Q2	$457K	Buy	7,234 +1,201	+20%	+$60.9K	0.02%	759
2019 Q1	$291K	Hold	6,033	–	–	0.01%	873
2018 Q4	$202K	Hold	6,033	–	–	0.01%	954
2018 Q3	$316K	Hold	6,033	–	–	0.01%	856
2018 Q2	$189K	Buy	6,033 +963	+19%	+$26.8K	0.01%	1097
2018 Q1	$111K	Hold	5,070	–	–	0.01%	1423
2017 Q4	$102K	Hold	5,070	–	–	﹤0.01%	1493
2017 Q3	$103K	Hold	5,070	–	–	﹤0.01%	1442
2017 Q2	$88K	Buy	5,070 +1,123	+28%	+$14.5K	﹤0.01%	1539
2017 Q1	$32K	Buy	+3,947	New	+$28.5K	﹤0.01%	2124

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Ameritas Investment Partners's NVCR Position: Q1 2026 in Review

Ameritas Investment Partners held its NovoCure (NVCR) position steady in Q1 2026 at 8,489 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Ameritas Investment Partners first reported a position in NVCR in Q1 2017 and has held it in 21 quarters since. The position peaked at $626K in Q4 2019. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Ameritas Investment Partners held 8,489 shares of NovoCure worth $92.5K as of Q1 2026.
Ameritas Investment Partners left its NovoCure share count unchanged in Q1 2026.
NovoCure made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1736 holding.
Ameritas Investment Partners first reported a position in NovoCure in Q1 2017 and has held it in 21 quarters since.
Ameritas Investment Partners's NovoCure position peaked at $626K in Q4 2019.
223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.